US Patent

US9012484 — Crystal and pharmaceutical preparation containing the same crystal

Method of Use · Assigned to Pola Pharma Inc · Expires 2033-09-06 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a crystal form of luliconazole, specifically one combined with a short chain alcohol having 1-4 carbon atoms, to improve its solubility.

USPTO Abstract

An object is to provide means for improving the solubility of luliconazole. Disclosed is a crystal consisting of luliconazole and short chain alcohol having a number of carbon atom or atoms of 1 to 4.

Drugs covered by this patent

Luzu (LULICONAZOLE) · Bausch Health

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-540`	—	Luzu

Patent Metadata

Patent number: US9012484
Jurisdiction: US
Classification: Method of Use
Expires: 2033-09-06
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Pola Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.